CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 89 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $366,000 | -41.7% | 36,163 | -35.3% | 0.00% | -50.0% |
| Q2 2016 | $628,000 | -17.8% | 55,934 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $764,000 | -28.0% | 55,934 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $1,061,000 | +1.0% | 55,934 | 0.0% | 0.01% | -10.0% |
| Q3 2015 | $1,050,000 | – | 55,934 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |